Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Greenlane to Present at the Canaccord Genuity US Cannabis Symposium
-
Greenlane to Present at the Canaccord Genuity US Cannabis Symposium
-
Halo to Present at the 2019 US Cannabis Symposium Hosted by Canaccord Genuity in Toronto, Ontario on October 3rd
-
Curaleaf Announces October Conference Attendance
-
Xtraction Services President & CEO David Kivitz to Present in Toronto on October 2nd and 3rd, 2019
-
Green Thumb Industries (GTI) Founder and Chief Executive Officer Ben Kovler to Present at the Canaccord Genuity U.S. Cannabis Symposium on October 3, 2019
-
Green Thumb Industries (GTI) Founder and Chief Executive Officer Ben Kovler to Present at the Canaccord Genuity U.S. Cannabis Symposium on October 3, 2019
-
Form 8.3 - [Accesso Technology Group plc] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Questor Technology (QUTIF)
-
Canaccord Genuity Reiterates Buy Rating on Osisko Gold Royalties Ltd. (OR)
-
Canaccord Genuity Reiterates Spec. Buy Rating on Great Bear Resources Ltd. (GTBDF)
-
Canaccord Genuity Reiterates Buy Rating on Alimentation Couche-Tard Inc (ANCUF)
-
Canaccord Genuity Reiterates Hold Rating on AltaGas Ltd. (ATGFF)
-
Ianthus Capital Holdings (IAN:CN) (ITHUF) PT Lowered to Cdn$8.50 at Canaccord Genuity
-
Canaccord Genuity Starts Flower One Holdings Inc. (FONE:CN) (FLOOF) at Spec. Buy
-
Canaccord Genuity Upgrades Ericsson (ERIC) to Buy
-
TransGlobe Energy Corporation Announces Director/PDMR Shareholding
-
Rebel Capital Inc. Provides Further Update for Proposed Qualifying Transaction
-
Transaction in Own Shares
-
Canaccord Genuity Reiterates Buy Rating on Bicycle Therapeutics (BCYC)
-
Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
-
Canaccord Genuity Reiterates Buy Rating on Premier Gold Mines Ltd. (PIRGF)
-
Canaccord Genuity Reiterates Spec. Buy Rating on Just Energy Group Inc. (JE)
-
Canaccord Genuity Reiterates Buy Rating on Enbridge Inc. (ENB)
-
Canaccord Genuity Starts Hamilton Thorne Ltd. (HTL:CN) (HTLZF) at Buy
-
Canaccord Genuity Starts Akumin (AKU-U:CN) (AKMNF) at Buy
-
SSP Group Plc. (SSPG:LN) (SSPPF) PT Raised to GBp680 at Canaccord Genuity
-
Celtic Plc. (CCP:LN) (CLTFF) PT Raised to GBp190 at Canaccord Genuity
-
Canaccord Genuity Downgrades Spirent Communications Plc. (SPT:LN) (SPNUF) to Hold
-
Form 8.3 - [Telford Homes plc] - CGWL
-
Annual Financial Report
-
TransGlobe Energy Corporation Announces PDMR Shareholding
-
Absolute Announces Renewal of Share Buyback Program
-
TerrAscend to Present at Upcoming Conferences
-
HTG Molecular Diagnostics (HTGM) PT Lowered to $1.50 at Canaccord Genuity
-
CalAmp Corp. (CAMP) PT Raised to $24 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Superior Plus Corp (SUUIF)
-
Canaccord Genuity Reiterates Buy Rating on Stingray Digital Group Inc. ()
-
Canaccord Genuity Reiterates Hold Rating on Plaza Retail REIT (PAZRF)
-
Brookfield Asset Management (BAM) PT Raised to $62 at Canaccord Genuity
-
Gamesys Group PLC Announces Admission of New JPJ Shares
-
Gamesys Group PLC Announces Admission of New JPJ Shares
-
Discovery 2019 Short Duration LP Second Closing October 23, 2019
-
Peloton (PTON) IPO Opens 7% Lower
-
JPJ Group PLC Announces Completion of Acquisition of Gamesys
-
JPJ Group PLC Announces Completion of Acquisition of Gamesys
-
AAR Corporation (AIR) PT Raised to $52 at Canaccord Genuity
-
Peloton (PTON) Prices 40M Class A Share IPO at $29/Sh
-
Troilus Announces Intention to Complete up to C$6,000,000 Non-Brokered Private Placement of Flow-Through Shares
-
VAALCO Energy, Inc. Admission to Trading and First Day of Dealings

